GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » FCF Margin %

PharmaTher Holdings (XCNQ:PHRM) FCF Margin % : 0.00% (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PharmaTher Holdings's Free Cash Flow for the three months ended in Feb. 2024 was C$-0.72 Mil. PharmaTher Holdings's Revenue for the three months ended in Feb. 2024 was C$0.00 Mil. Therefore, PharmaTher Holdings's FCF Margin % for the quarter that ended in Feb. 2024 was 0.00%.

As of today, PharmaTher Holdings's current FCF Yield % is -20.13%.

The historical rank and industry rank for PharmaTher Holdings's FCF Margin % or its related term are showing as below:


XCNQ:PHRM's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -139.31
* Ranked among companies with meaningful FCF Margin % only.


PharmaTher Holdings FCF Margin % Historical Data

The historical data trend for PharmaTher Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings FCF Margin % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
FCF Margin %
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's FCF Margin %

For the Biotechnology subindustry, PharmaTher Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's FCF Margin % falls into.



PharmaTher Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PharmaTher Holdings's FCF Margin for the fiscal year that ended in May. 2023 is calculated as

FCF Margin=Free Cash Flow (A: May. 2023 )/Revenue (A: May. 2023 )
=-3.235/0
= %

PharmaTher Holdings's FCF Margin for the quarter that ended in Feb. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-0.723/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines